Public insider research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Insider research history

Emily Randall

Public disclosure history for this insider, with previous signal outcomes and source links kept visible for research review.

11 disclosures
0 buys
11 sells
-1.3% avg. 30d outcome (11 of 11)

Insider facts

Role
Representative
Country
US
Party
Democratic
Type
POLITICIAN
Repeat disclosures
0

Politician review

Historical research metrics from promoted public disclosures only. This is not investment advice.

93% avg. data confidence

Hypothetical 30d win rate
5 of 11 positive outcomes
Best reviewed outcome
+8.0% best 30d outcome
Weakest reviewed outcome
-14.0% weakest 30d outcome

Repeated sectors

  • Unclassified, 11 disclosures

Repeated companies

No repeated companies yet.

Disclosure history

Abbott Laboratories Common Stock (ABT)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
-1.2%

Alphabet Inc. - Class C Capital Stock (GOOG)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
-11.8%

Wells Fargo & Company Common Stock (WFC)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
-14.0%

Amgen Inc. - Common Stock (AMGN)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
+6.2%

Exxon Mobil Corporation Common Stock (XOM)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
-1.8%

Fortive Corporation Common Stock (FTV)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
-10.3%

Medtronic plc. Ordinary Shares (MDT)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
+1.2%

Mondelez International, Inc. - Class A Common Stock (MDLZ)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
+7.0%

Pepsico, Inc. (PEP)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
+2.8%

Procter & Gamble Company (PG)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
-0.5%

Verizon Communications Inc. Common Stock (VZ)

sell disclosed on 11 Feb 2025 via House STOCK Act disclosures

Transaction value
US$1,001
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
+8.0%